Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin trial results by Genentech.
Article | November 25, 2021
Dear Friends,
I want to share with you the latest news on Avastin® (bevacizumab), a treatment for patients with glioblastoma, the most common and aggressive form of brain cancer.
This fall, ABC2 supporters had the unique opportunity to learn first-hand about the latest advances in brain tumor research at a series of ABC2 Science Salon events across the country.
Dear Friends,
